Dayker Fernandez
Land O Lakes, FLNPI 1225859523
Payments from drug & device makers
Across 100 payments — averaging $27.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$675
- AstraZeneca$391
- Novo Nordisk$278
- Renalytix AI, Inc.$266
- Bayer$213
- Merz North America, Inc.$191
- plus $693 from 12 others
What the payments were for
- Food & beverage$2,707100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 15 | $675 |
| AstraZeneca | 16 | $391 |
| Novo Nordisk | 14 | $278 |
| Renalytix AI, Inc. | 9 | $266 |
| Bayer | 10 | $213 |
| Merz North America, Inc. | 3 | $191 |
| GSK | 9 | $156 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $124 |
| Alkermes, Inc. | 5 | $122 |
| Aimmune Therapeutics, Inc. | 4 | $81 |
| Boehringer Ingelheim | 2 | $44 |
| Sanofi-aventis U.S. LLC | 2 | $41 |
| Pfizer | 1 | $24 |
| Merck | 1 | $23 |
| Ardelyx, Inc. | 1 | $23 |
| Exact Sciences | 1 | $22 |
| Lundbeck LLC | 1 | $20 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.